These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Antipyrine clearance and metabolism in patients with psoriasis. Kubota K; Ishizaki T; Chiba K; Takagi A; Nakagawa A; Nakamura K Br J Clin Pharmacol; 1986 Oct; 22(4):455-62. PubMed ID: 3768257 [TBL] [Abstract][Full Text] [Related]
5. Benzo(a)pyrene metabolism and plasma elimination rates of phenacetin, acetanilide and theophylline in man. Kellermann G; Luyten-Kellermann M Pharmacology; 1978; 17(4):191-200. PubMed ID: 693568 [TBL] [Abstract][Full Text] [Related]
6. Correlations between cytochrome P-450 and oxidative metabolism of benzo[a]pyrene and 7-ethoxycoumarin in human liver in vitro and antipyrine elimination in vivo. Pelkonen O; Sotaniemi E; Tokola O; Ahokas JT Drug Metab Dispos; 1980; 8(4):218-22. PubMed ID: 6105054 [TBL] [Abstract][Full Text] [Related]
7. Hepatic microsomal drug metabolism, glutamyl transferase activity and in vivo antipyrine half-life in rats chronically fed an ethanol diet, a control diet and a chow diet. Gadeholt G; Aarbakke J; Dybing E; Sjöblom M; Mørland J J Pharmacol Exp Ther; 1980 Apr; 213(1):196-203. PubMed ID: 6102148 [TBL] [Abstract][Full Text] [Related]
8. Correlation of aryl hydrocarbon hydroxylase activity of human lymphocyte cultures and plasma elimination rates for antipyrine and phenylbutazone. Kellermann G; Luyten-Kellermann M; Horning M; Stafford M Drug Metab Dispos; 1975; 3(1):47-50. PubMed ID: 234834 [TBL] [Abstract][Full Text] [Related]
9. Alterations of drug metabolism in rats exposed to cigarette smoke. Farrell GC; Cooksley WG; Cash GA; Powell LW Aust J Exp Biol Med Sci; 1980 Dec; 58(6):585-90. PubMed ID: 7271596 [TBL] [Abstract][Full Text] [Related]
10. Saliva and plasma clearance of antipyrine as reflectors of liver function. Luoma PV; Sotaniemi EA Eur J Drug Metab Pharmacokinet; 1981; 6(4):261-4. PubMed ID: 7333326 [TBL] [Abstract][Full Text] [Related]
16. Salivary antipyrine kinetics in hepatic and renal disease and in patients on anticonvulsant therapy. Harman AW; Penhall RK; Priestly BG; Frewin DB; Phillips PJ; Clarkson AR Aust N Z J Med; 1977 Aug; 7(4):385-90. PubMed ID: 270989 [TBL] [Abstract][Full Text] [Related]
17. Effect of a non-steroid anti-inflammatory agent on the drug metabolizing activity of the human liver. Gachályi B; Vas A; Káldor A Int J Clin Pharmacol Ther Toxicol; 1984 Jul; 22(7):353-4. PubMed ID: 6469424 [TBL] [Abstract][Full Text] [Related]
18. Metabolic disposition of antipyrine in patients with lung cancer. Tschanz C; Hignite CE; Huffman DH; Azarnoff DL Cancer Res; 1977 Nov; 37(11):3881-6. PubMed ID: 908027 [TBL] [Abstract][Full Text] [Related]
19. Aryl hydrocarbon hydroxylase in man and lung cancer. Kellermann G; Luyten-Kellermann M; Jett JR; Moses HL; Fontana RS Hum Genet Suppl; 1978; (1):161-8. PubMed ID: 285027 [No Abstract] [Full Text] [Related]